$38.50
-0.8-2.04%
At Close: -
$39.85
1.353.51%
After Hours: 8:12 AM EDT
15 minutes delayed
Janux Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Janux Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
JANX | Janux Therapeutics | -$0.42 | -$0.33 | — | — | $1.06M | $720.00K | — | — | 08/06/2024 | Get Alert |
JANX | Janux Therapeutics | -$0.42 | -$0.33 | -$0.30 | 9.09% | $2.05M | $760.00K | $1.25M | 64.74% | 05/07/2024 | Get Alert |
JANX | Janux Therapeutics | -$0.39 | -$0.40 | -$0.25 | 37.50% | $2.85M | $750.00K | $2.46M | 228.13% | 03/08/2024 | Get Alert |
JANX | Janux Therapeutics | -$0.40 | -$0.47 | -$0.25 | 46.81% | $1.81M | $850.00K | $2.52M | 196.12% | 11/07/2023 | Get Alert |
JANX | Janux Therapeutics | -$0.41 | -$0.52 | -$0.42 | 19.23% | $2.37M | $870.00K | $1.06M | 21.49% | 08/08/2023 | Get Alert |
JANX | Janux Therapeutics | -$0.32 | -$0.49 | -$0.42 | 14.29% | $1.59M | $670.00K | $2.05M | 205.67% | 05/09/2023 | Get Alert |
JANX | Janux Therapeutics | -$0.33 | -$0.49 | -$0.39 | 20.41% | $1.62M | $790.00K | $2.85M | 260.13% | 03/10/2023 | Get Alert |
JANX | Janux Therapeutics | -$0.26 | -$0.49 | -$0.40 | 18.37% | $1.16M | $740.00K | $1.81M | 145.00% | 11/10/2022 | Get Alert |
JANX | Janux Therapeutics | -$0.62 | -$0.37 | -$0.41 | -10.81% | $482.00K | $850.00K | $2.37M | 178.24% | 08/09/2022 | Get Alert |
JANX | Janux Therapeutics | -$2.06 | -$0.37 | -$0.32 | 13.51% | $380.00K | $820.00K | $1.59M | 93.78% | 05/10/2022 | Get Alert |
JANX | Janux Therapeutics | -$1.65 | -$0.31 | -$0.33 | -6.45% | — | — | $1.62M | — | 03/18/2022 | Get Alert |
JANX | Janux Therapeutics | -$1.33 | -$0.18 | -$0.26 | -44.44% | — | $130.00K | $1.16M | 791.54% | 11/09/2021 | Get Alert |
JANX | Janux Therapeutics | -$2.76 | — | -$0.62 | — | — | — | $482.00K | — | 08/10/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $-0.30 | $-0.33 | 9.09 % |
Dec 2023 | 2024-03-08 | $-0.25 | $-0.40 | 37.5 % |
Sep 2023 | 2023-11-07 | $-0.25 | $-0.47 | 46.8 % |
Jun 2023 | 2023-08-08 | $-0.42 | $-0.52 | 19.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $1.25M | $760.00K | 64.7 % |
Dec 2023 | 2024-03-08 | $2.46M | $750.00K | 228.1 % |
Sep 2023 | 2023-11-07 | $2.52M | $850.00K | 196.1 % |
Jun 2023 | 2023-08-08 | $1.06M | $870.00K | 21.5 % |
Janux Therapeutics (JANX) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
The Actual EPS was $-0.30, which beat the estimate of $-0.33.
The Actual Revenue was $1.3M, which beat the estimate of $760K.
Browse earnings estimates, EPS, and revenue on all stocks.